NK Cell Therapy for Immune Health: What to Ask First

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Why people ask about NK cell therapy for immune health maintenance

Most conversations about NK cell therapy focus on people who are currently being treated for cancer. Yet some visitors to Grand Green Osaka Umekita Clinic in Osaka ask a different question: can the therapy also be considered for maintaining immune function, even when no active treatment is under way? The clinic’s information describes the therapy as something that can be received with the aim of preventing recurrence after cancer treatment or maintaining immune function.

That wording describes an aim, not a promised result. Nobody can say in advance how an individual immune system will respond, and the reasons for asking differ widely. Some people have finished cancer treatment and want to talk about what comes next. Others are simply curious after learning that natural killer cells are thought to decline with age and stress. This article explains how to think about the question and what to bring to a consultation.

What NK cells do and what the therapy involves

NK (natural killer) cells are a type of lymphocyte that circulates in the blood. They are part of the innate immune system and can detect and attack abnormal cells and virus-infected cells without waiting for instructions from other immune cells. Healthy people are thought to produce abnormal cells every day, and immune surveillance, in which cells such as NK cells find and remove them, is thought to be one reason most people do not develop cancer.

In NK cell therapy, a sample of your own blood is collected in a standard blood draw. At a licensed cell processing facility, the NK cells are activated and expanded outside the body. The cells are then returned to you by intravenous infusion. Because your own cells are used, the risk of rejection is considered low, although temporary fever or fatigue may occur. The aim is to return NK cells that are greater in number and higher in activity, which is why it is described as working with your own immunity rather than replacing other care.

What the evidence can and cannot tell you

When the goal is maintenance rather than treatment of a visible tumor, it is harder to define what success would look like. Blood tests can measure certain immune markers, but a change in a laboratory value does not automatically mean a change in your long-term health. Research on NK cell approaches is ongoing, and results from one study or one patient group should not be generalized to everyone.

For that reason, it is reasonable to ask a doctor which published studies are relevant to your situation, how those studies were designed, and where the uncertainty lies. Public sources such as PubMed, the Japanese Ministry of Health, Labour and Welfare, and academic society guidelines are good starting points for your own reading. If someone describes the therapy in absolute terms, treat that as a signal to ask more questions rather than fewer.

How it relates to standard cancer care and regular check-ups

NK cell therapy is not a substitute for standard cancer treatment such as surgery, chemotherapy, or radiation therapy, and it is not a replacement for scheduled follow-up examinations or screening. The clinic states that the therapy is intended to be used alongside these treatments rather than in place of them, and that it can coordinate with the medical institution providing your standard care.

If you have a history of cancer, tell your oncologist that you are considering this option before you decide. Share the proposed schedule and the clinic’s contact details so that both teams understand your overall plan. If you have no cancer history, a general check-up and the screening programs recommended for your age remain the foundation of preventive care. Any immune therapy would be an additional topic to discuss, not a first step.

Questions to ask before starting in Osaka

The therapy is provided as a self-pay (non-insured) treatment in Japan, under a regenerative medicine provision plan submitted to and accepted by the authorities under the Act on the Safety of Regenerative Medicine. Fees, number of sessions, schedule, risks, side effects, and whether the therapy suits your circumstances all need to be confirmed with a doctor at consultation. Before you go, consider preparing the following questions.

• What is the exact purpose of treatment in my case, and how would we judge whether it is worthwhile?
• What are the total costs, including consultation, tests, and each infusion, and what does the schedule look like?
• What temporary effects, such as fever or fatigue, can occur, and what should I do if they appear?
• How is the processing facility regulated, and where can I read the provision plan information?
• How will my records be shared with my oncologist or family doctor?

The clinic offers information pages in several languages and a dedicated route for international patients, so you can begin by reading the English information and then arrange a consultation through the web or LINE. If you live overseas, ask about timing and how your records can be shared with your home doctors. A careful, unhurried consultation is more useful than a quick decision.

Key points to take away

NK cell therapy uses your own activated and expanded NK cells, returned by intravenous infusion. It may be considered for different purposes, including maintaining immune function, but the expected benefit differs from person to person and cannot be guaranteed in advance. Standard treatment and regular check-ups stay at the center of your care.

If you are interested, a consultation at Grand Green Osaka Umekita Clinic is the place to discuss whether it fits your situation. Bring your medical history, ask about cost, risks, and limits, and involve your regular doctors in the decision.

• Clarify your purposeAsk what the aim is in your case
• Keep standard careCheck-ups and treatment stay central
• Confirm cost and risksSelf-pay; discuss with a doctor
• Involve your doctorsShare plans with your oncologist

This figure is a conceptual diagram that summarizes the content of the article

References

• PubMed: Natural killer cell therapies. (2024)
• PubMed: Natural killer cell-based immunotherapy for cancer. (2025)
• PubMed: Allogeneic natural killer cell therapy. (2023)
• PubMed: Selection and expansion of natural killer cells for NK cell-based immunotherapy. (2016)
• PubMed: Targeted in vivo delivery of genetic medicines utilizing an engineered lentiviral vector platform results in CAR T and NK cell generation. (2025)
• PMC: Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. (2019)
• PMC: NK Cells in Cancer: Mechanisms of Dysfunction and Therapeutic Potential. (2023)
• PMC: Natural killer cell-based immunotherapy for cancer. (2025)
• MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.